Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian J Majewski

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
The Journal of Experimental Medicine|March 15, 2023
Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competitionHesham D Abdulla, Raed Alserihi, Christoffer Flensburg, et al.
Cancer Research|December 28, 2012
Epigenetic regulator Smchd1 functions as a tumor suppressorHuei San Leong, Kelan Chen, Yifang Hu, et al.
Blood|May 7, 2010
Opposing roles of polycomb repressive complexes in hematopoietic stem and progenitor cellsIan J Majewski, Matthew E Ritchie, Belinda Phipson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 2006
A mutation in the translation initiation codon of Gata-1 disrupts megakaryocyte maturation and causes thrombocytopeniaIan J Majewski, Donald Metcalf, Lisa A Mielke, et al.
Blood|June 4, 2015
Polycomb repressive complex 2 component Suz12 is required for hematopoietic stem cell function and lymphopoiesisStanley C W Lee, Sarah Miller, Craig Hyland, et al.
Pediatric Blood & Cancer|June 29, 2019
Targeted therapy and disease monitoring in CNTRL-FGFR1-driven leukaemiaLauren M Brown, Ray C Bartolo, Nadia M Davidson, et al.
Plos Biology|April 18, 2008
Polycomb repressive complex 2 (PRC2) restricts hematopoietic stem cell activityIan J Majewski, Marnie E Blewitt, Carolyn A de Graaf, et al.
Blood|August 29, 2013
Polycomb repressive complex 2 (PRC2) suppresses Eμ-myc lymphomaStanley C W Lee, Belinda Phipson, Craig D Hyland, et al.
The Journal of Pathology|December 5, 2012
An α-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancerIan J Majewski, Irma Kluijt, Annemieke Cats, et al.
Nature Communications|June 5, 2019
Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutationsRichard W Birkinshaw, Jia-Nan Gong, Cindy S Luo, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
The Journal of Experimental Medicine|March 15, 2023
Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competitionHesham D Abdulla, Raed Alserihi, Christoffer Flensburg, et al.
Cancer Research|December 28, 2012
Epigenetic regulator Smchd1 functions as a tumor suppressorHuei San Leong, Kelan Chen, Yifang Hu, et al.
Blood|May 7, 2010
Opposing roles of polycomb repressive complexes in hematopoietic stem and progenitor cellsIan J Majewski, Matthew E Ritchie, Belinda Phipson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 2006
A mutation in the translation initiation codon of Gata-1 disrupts megakaryocyte maturation and causes thrombocytopeniaIan J Majewski, Donald Metcalf, Lisa A Mielke, et al.
Blood|June 4, 2015
Polycomb repressive complex 2 component Suz12 is required for hematopoietic stem cell function and lymphopoiesisStanley C W Lee, Sarah Miller, Craig Hyland, et al.
Pediatric Blood & Cancer|June 29, 2019
Targeted therapy and disease monitoring in CNTRL-FGFR1-driven leukaemiaLauren M Brown, Ray C Bartolo, Nadia M Davidson, et al.
Plos Biology|April 18, 2008
Polycomb repressive complex 2 (PRC2) restricts hematopoietic stem cell activityIan J Majewski, Marnie E Blewitt, Carolyn A de Graaf, et al.
Blood|August 29, 2013
Polycomb repressive complex 2 (PRC2) suppresses Eμ-myc lymphomaStanley C W Lee, Belinda Phipson, Craig D Hyland, et al.
The Journal of Pathology|December 5, 2012
An α-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancerIan J Majewski, Irma Kluijt, Annemieke Cats, et al.
Nature Communications|June 5, 2019
Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutationsRichard W Birkinshaw, Jia-Nan Gong, Cindy S Luo, et al.
Pageof 5